New guidance and information for industry from the MHRA

4th January 2021

The transition period for the United Kingdom's departure from the EU is over and new guidance in a matter of areas has been released by the MHRA.

The areas are:

Clinical trials
Devices
Importing and exporting
IT systems
Legislation
Licensing
Pharmacovigilance
Paediatrics

Click here for more.

Back to News Archive